Enzymology of bioreductive drug activation.
作者信息
Ross D, Beall H D, Siegel D, Traver R D, Gustafson D L
机构信息
School of Pharmacy, University of Colorado Health Sciences Center, Denver 80262, USA.
出版信息
Br J Cancer Suppl. 1996 Jul;27:S1-8.
Abstract
摘要
相似文献
1
Enzymology of bioreductive drug activation.生物还原药物激活的酶学
Br J Cancer Suppl. 1996 Jul;27:S1-8.
2
Induction of DT-diaphorase by 1,2-dithiole-3-thione and increase of antitumour activity of bioreductive agents.1,2-二硫杂环戊烯-3-硫酮诱导DT-黄递酶并增强生物还原药物的抗肿瘤活性。
Br J Cancer Suppl. 1996 Jul;27:S9-14.
3
Bioreductive agents: a clinical update.生物还原剂：临床最新进展
Oncol Res. 1997;9(6-7):391-5.
4
Relative importance of DT-diaphorase and hypoxia in the bioactivation of EO9 by human lung tumor cell lines.人肺肿瘤细胞系中DT-黄递酶和缺氧在EO9生物活化中的相对重要性。
Int J Radiat Oncol Biol Phys. 1994 May 15;29(2):295-9. doi: 10.1016/0360-3016(94)90278-x.
5
Development, pharmacology, role of DT-diaphorase and prospects of the indoloquinone EO9.吲哚醌EO9的研发、药理学、DT-黄递酶的作用及前景
Gen Pharmacol. 1996 Apr;27(3):421-9. doi: 10.1016/0306-3623(95)00118-2.
6
Xanthine dehydrogenase and its role in cancer chemotherapy.
Oncol Res. 1994;6(10-11):477-81.
7
Bioreductive activation of a series of analogues of 5-aziridinyl-3-hydroxymethyl-1-methyl-2-[1H-indole-4, 7-dione] prop-beta-en-alpha-ol (EO9) by human DT-diaphorase.人DT-黄递酶对一系列5-氮丙啶基-3-羟甲基-1-甲基-2-[1H-吲哚-4,7-二酮]丙-β-烯-α-醇（EO9）类似物的生物还原激活作用。
Biochem Pharmacol. 1996 Dec 13;52(11):1711-8. doi: 10.1016/s0006-2952(96)00521-7.
8
Indoloquinone EO9: DNA interstrand cross-linking upon reduction by DT-diaphorase or xanthine oxidase.吲哚醌EO9：经DT-黄递酶或黄嘌呤氧化酶还原后形成DNA链间交联。
Br J Cancer. 1995 Apr;71(4):836-9. doi: 10.1038/bjc.1995.161.
9
Bioreductive activation of a series of indolequinones by human DT-diaphorase: structure-activity relationships.人DT-黄递酶对一系列吲哚醌的生物还原激活作用：构效关系
J Med Chem. 1999 Oct 7;42(20):4071-80. doi: 10.1021/jm991063z.
10
The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.功能基团对DT-黄递酶还原和激活醌类生物还原剂的影响。
Cancer Chemother Pharmacol. 2002 Feb;49(2):101-10. doi: 10.1007/s00280-001-0395-1. Epub 2001 Nov 24.
引用本文的文献
1
Human NQO1 as a Selective Target for Anticancer Therapeutics and Tumor Imaging.人类 NQO1 作为抗癌治疗和肿瘤成像的选择性靶标。
Cells. 2024 Jul 29;13(15):1272. doi: 10.3390/cells13151272.
2
NQO1 regulates cell cycle progression at the G2/M phase.NQO1 在 G2/M 期调控细胞周期进程。
Theranostics. 2023 Jan 10;13(3):873-895. doi: 10.7150/thno.77444. eCollection 2023.
3
Roles of NAD(P)H:quinone Oxidoreductase 1 in Diverse Diseases.NAD(P)H：醌氧化还原酶1在多种疾病中的作用。
Life (Basel). 2021 Nov 26;11(12):1301. doi: 10.3390/life11121301.
4
The diverse functionality of NQO1 and its roles in redox control.NQO1 的多样化功能及其在氧化还原控制中的作用。
Redox Biol. 2021 May;41:101950. doi: 10.1016/j.redox.2021.101950. Epub 2021 Mar 20.
5
The diverse mechanisms and anticancer potential of naphthoquinones.萘醌类化合物的多种作用机制及抗癌潜力
Cancer Cell Int. 2019 Aug 2;19:207. doi: 10.1186/s12935-019-0925-8. eCollection 2019.
6
Luminescent Probe Based Techniques for Hypoxia Imaging.基于发光探针的缺氧成像技术
J Nanomed Res. 2017;6(3). doi: 10.15406/jnmr.2017.06.00160. Epub 2017 Nov 20.
7
Oxidative stress and cell damage in a model of precancerous lesions and advanced hepatocellular carcinoma in rats.大鼠癌前病变和晚期肝细胞癌模型中的氧化应激与细胞损伤
Toxicol Rep. 2014 Nov 28;2:333-340. doi: 10.1016/j.toxrep.2014.11.015. eCollection 2015.
8
Flavoenzyme-mediated reduction reactions and antitumor activity of nitrogen-containing tetracyclic ortho-quinone compounds and their nitrated derivatives.含氮四环邻醌化合物及其硝化衍生物的黄素酶介导还原反应和抗肿瘤活性
EXCLI J. 2017 May 11;16:663-678. doi: 10.17179/excli2017-273. eCollection 2017.
9
In Vivo Imaging of Retinal Hypoxia in a Model of Oxygen-Induced Retinopathy.氧诱导性视网膜病变模型中视网膜缺氧的体内成像
Sci Rep. 2016 Aug 5;6:31011. doi: 10.1038/srep31011.
10
Xanthine Oxidoreductase in Drug Metabolism: Beyond a Role as a Detoxifying Enzyme.药物代谢中的黄嘌呤氧化还原酶：超越解毒酶的作用
Curr Med Chem. 2016;23(35):4027-4036. doi: 10.2174/0929867323666160725091915.
本文引用的文献
1
On the catalytic function of heart flavoprotein.关于心脏黄素蛋白的催化功能。
Biochem J. 1939 May;33(5):793-801. doi: 10.1042/bj0330793.
2
Coenzyme factor-a new oxidation catalyst.辅酶因子——一种新型氧化催化剂。
Biochem J. 1938 Mar;32(3):626-39. doi: 10.1042/bj0320626.
3
MITOMYCINS AND PORFIROMYCIN: CHEMICAL MECHANISM OF ACTIVATION AND CROSS-LINKING OF DNA.丝裂霉素和卟吩姆：DNA激活与交联的化学机制
Science. 1964 Jul 3;145(3627):55-8. doi: 10.1126/science.145.3627.55.
4
5
Reductive activation of mitomycin C by NADH:cytochrome b5 reductase.NADH：细胞色素b5还原酶对丝裂霉素C的还原激活作用。
Cancer Res. 1993 Oct 15;53(20):4907-12.
6
The case for mitomycin in non-small cell lung cancer.
Oncology. 1993 Apr;50 Suppl 1:35-50. doi: 10.1159/000227246.
7
The one-electron reduction potential of several substrates can be related to their reduction rates by cytochrome P-450 reductase.
Biochim Biophys Acta. 1993 Jan 15;1161(1):73-8. doi: 10.1016/0167-4838(93)90198-z.
8
DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C.DT-黄递酶在醌类的激活与解毒过程中的作用。丝裂霉素C的生物还原激活作用。
Cancer Metastasis Rev. 1993 Jun;12(2):83-101. doi: 10.1007/BF00689803.
9
10
Expression of NAD(P)H:quinone oxidoreductase and glutathione S-transferases alpha and pi in human renal cell carcinoma and in kidney cancer-derived cell lines.NAD(P)H：醌氧化还原酶以及谷胱甘肽S-转移酶α和π在人肾细胞癌及肾癌衍生细胞系中的表达
Carcinogenesis. 1994 Feb;15(2):219-25. doi: 10.1093/carcin/15.2.219.
Zotero 插件